VIDA, RICCARDO
 Distribuzione geografica
Continente #
AS - Asia 101
EU - Europa 64
NA - Nord America 63
SA - Sud America 13
AF - Africa 1
Totale 242
Nazione #
US - Stati Uniti d'America 61
SG - Singapore 48
IT - Italia 35
CN - Cina 27
BR - Brasile 12
DE - Germania 7
VN - Vietnam 7
HK - Hong Kong 6
NL - Olanda 5
TR - Turchia 4
AT - Austria 3
FR - Francia 3
GB - Regno Unito 3
RU - Federazione Russa 3
BD - Bangladesh 2
FI - Finlandia 2
IE - Irlanda 2
KR - Corea 2
BH - Bahrain 1
CO - Colombia 1
DK - Danimarca 1
IR - Iran 1
JP - Giappone 1
MX - Messico 1
NP - Nepal 1
PH - Filippine 1
SC - Seychelles 1
SV - El Salvador 1
Totale 242
Città #
Singapore 24
Ashburn 15
San Jose 10
Arezzo 8
Council Bluffs 7
Hong Kong 5
Santa Clara 4
Shenzhen 4
Beijing 3
Ho Chi Minh City 3
Venice 3
Vienna 3
Ankara 2
Belluno 2
Buffalo 2
Dublin 2
Frankfurt am Main 2
Hefei 2
Helsinki 2
Kunming 2
Lauterbourg 2
Los Angeles 2
Milan 2
Mirano 2
New York 2
Palermo 2
Porcia 2
Roccamonfina 2
Rome 2
Seoul 2
Shanghai 2
Antônio Gonçalves 1
Boardman 1
Bucaramanga 1
Caorle 1
Chicago 1
Dallas 1
Deiva Marina 1
Denver 1
Genoa 1
Guaraciaba do Norte 1
Hamad Town 1
Hanoi 1
Heilbronn 1
Helena 1
Houston 1
Hải Dương 1
Ilha das Flores 1
Istanbul 1
Jequié 1
Macedônia 1
Manila 1
Mexico City 1
Munich 1
Naaldwijk 1
Nottingham 1
Poplar 1
Preston 1
Quixadá 1
San Francisco 1
San Salvador 1
Santo Antônio do Monte 1
Senador Firmino 1
São Raimundo Nonato 1
São Vicente 1
Tehran 1
Teutônia 1
Tokyo 1
Turin 1
Vicenza 1
Volta Redonda 1
Yalova 1
Totale 168
Nome #
Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer? 114
Beyond Hormone Receptors: liquid biopsy tools to unveil new clinical meanings and empower therapeutic decision-making in Luminal-like metastatic breast cancer 60
Idiosyncratic Drug-Induced Liver Injury and Trastuzumab Deruxtecan in Breast Cancer: A Case Report 32
Effectiveness of azacytidine for poly ADP-ribose polymerase inhibitor-induced myelodysplastic syndrome in ovarian cancer patient: a twofold triumph 19
Immunotherapy with anti-PD-1 or PD-L1 in advanced ovarian cancer: A meta-analysis of randomized trials 19
Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial Cancer 16
Totale 260
Categoria #
all - tutte 702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20243 0 0 0 0 0 0 0 0 0 0 0 3
2024/202590 18 3 9 0 3 2 4 13 15 5 10 8
2025/2026167 9 13 9 8 10 6 33 15 46 18 0 0
Totale 260